Role of endocannabinoid system in the pathogenesis of obesity: how can we help a patient? From theory to practice

Obesity that results in various metabolic disorders is one of the central concerns of modern healthcare system. Only 4% to 5% of patients with metabolic syndrome achieve favorable outcomes without any additional pharmacotherapy. Therefore, many patients require weight-loss drugs in addition to non-p...

Full description

Saved in:
Bibliographic Details
Published inРМЖ: Медицинское обозрение Vol. 4; no. 6; pp. 382 - 389
Main Authors Dudareva, V.A., Maksimov, M.L., Djadikova, I.G., Zveginceva, A.A., Vovk, V.O., Shikaleva, A.A.
Format Journal Article
LanguageEnglish
Published 2020
Online AccessGet full text

Cover

Loading…